Joseph D. Mishkin, MD
Dr. Mishkin is board certified in internal medicine, cardiovascular diseases and advanced heart failure and transplantation. He specializes in cardiogenic shock (when the heart suddenly can't pump enough blood), heart failure and pulmonary hypertension (when the resistance of blood flowing through the lungs is too high). Additionally, he specializes in hypertrophic cardiomyopathy (a condition in which the heart becomes abnormally thick), cardiac amyloidosis (build up of proteins) and sarcoidosis (inflammation), heart transplantation and mechanical circulatory support. He serves as director of Cardiac Intensive Care Services at Atrium Health Sanger Heart & Vascular Institute.
Dr. Mishkin has received numerous awards, including Atrium Health Physician of the Quarter and North Carolina Top 100 Doctor. He’s also been nominated for the Atrium Health Teal Acorn Award and Pinnacle Award.
He’s currently involved in a variety of structural heart clinical trials (repair of damaged valves without open heart surgery) as well as an early-phase clinical trial investigating the use of an intracardiac (inside the heart) shunt for patients with symptomatic heart failure. He was also a primary investigator in a clinical trial involving the delivery of allogeneic (stem) cells into the heart to improve clinical outcomes, prevent cardiac remodeling (changes in the heart) and increase exercise capacity in patients with chronic heart failure due to LV systolic dysfunction who have received optimal medical therapy.
Dr. Mishkin received his medical degree at Indiana University and completed residency at the University of South Florida. He completed a cardiology fellowship at the University of South Florida and an advanced heart failure and transplantation fellowship at the University of Florida.
Joseph D. Mishkin
Dr. Mishkin is board certified in internal medicine, cardiovascular diseases and advanced heart failure and transplantation. He specializes in cardiogenic shock (when the heart suddenly can't pump enough blood), heart failure and pulmonary hypertension (when the resistance of blood flowing through the lungs is too high). Additionally, he specializes in hypertrophic cardiomyopathy (a condition in which the heart becomes abnormally thick), cardiac amyloidosis (build up of proteins) and sarcoidosis (inflammation), heart transplantation and mechanical circulatory support. He serves as director of Cardiac Intensive Care Services at Atrium Health Sanger Heart & Vascular Institute.
Dr. Mishkin has received numerous awards, including Atrium Health Physician of the Quarter and North Carolina Top 100 Doctor. He’s also been nominated for the Atrium Health Teal Acorn Award and Pinnacle Award.
He’s currently involved in a variety of structural heart clinical trials (repair of damaged valves without open heart surgery) as well as an early-phase clinical trial investigating the use of an intracardiac (inside the heart) shunt for patients with symptomatic heart failure. He was also a primary investigator in a clinical trial involving the delivery of allogeneic (stem) cells into the heart to improve clinical outcomes, prevent cardiac remodeling (changes in the heart) and increase exercise capacity in patients with chronic heart failure due to LV systolic dysfunction who have received optimal medical therapy.
Dr. Mishkin received his medical degree at Indiana University and completed residency at the University of South Florida. He completed a cardiology fellowship at the University of South Florida and an advanced heart failure and transplantation fellowship at the University of Florida.